| NCT ID | NCT05833048 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Condition | Cardiac Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2024-07-29 |
| Primary Completion | 2026-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2024-07-29 with a primary completion date of 2026-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, randomized study. The purpose of this study is to evaluate the effect of post-surgical pain control of a type of peripheral nerve block, Rectus Sheath Block. 1. Does the rectus sheath block decrease opioid consumption postoperatively after cardiac surgery? 2. Does the rectus sheath block decrease VAS pain scores postoperatively after cardiac surgery? Study participants will be assigned to receive either rectus sheath block or no block.
Eligibility Criteria
Inclusion Criteria: * In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Adults 18-85 years old 2. Scheduled to undergo cardiac procedures involving chest tubes 3. Male or female Exclusion Criteria: * An individual who meets any of the following criteria will be excluded from participation in this study: 1. ASA class V 2. Urgent or emergent surgery 3. Contraindications to administration of local anesthesia (e.g. local anesthetic allergy) 4. History of substance abuse or chronic opioid use 5. Patient refusal or inability to consent
Frequently Asked Questions
Who can join the NCT05833048 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Cardiac Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05833048 currently recruiting?
Yes, NCT05833048 is actively recruiting participants. Visit ClinicalTrials.gov or contact Icahn School of Medicine at Mount Sinai to inquire about joining.
Where is the NCT05833048 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT05833048 clinical trial?
NCT05833048 is sponsored by Icahn School of Medicine at Mount Sinai. The trial plans to enroll 75 participants.